Susan J. Knox

Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-Refractory Low-Grade or Transformed Low-Grade B-Cell Non-Hodgkin’s Lymphomas

Mark Kaminski, Andrew D. Zelenetz, Oliver W. Press et al. · Journal of Clinical Oncology · 2001 · 584 citations

Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line

Jeffrey S. Armstrong, Kirsten K Steinauer, Brita Hornung et al. · Cell Death and Differentiation · 2002 · 496 citations · Full text

Reductive Stress, Glutathione Depletion, Apoptosis +12

In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study

Joshua Brody, Weiyun Z. Ai, Debra K. Czerwinski et al. · Journal of Clinical Oncology · 2010 · 482 citations · Full text

Multicenter Phase II Study of Iodine-131 Tositumomab for Chemotherapy-Relapsed/Refractory Low-Grade and Transformed Low-Grade B-Cell Non-Hodgkin’s Lymphomas

Julie M. Vose, Richard L. Wahl, Mansoor N. Saleh et al. · Journal of Clinical Oncology · 2000 · 360 citations

Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma.

Susan J. Knox, Michael L. Goris, Kirk Trisler et al. · PubMed · 1996 · 332 citations

Hematological Malignancy, Lymphoid Neoplasia, Medicine +14